Full program and schedule for the AI x Biology Summit on October 21, 2026 at New York Genome Center. Explore sessions on AI-driven discovery, protein engineering, drug design, and precision medicine.

Bringing together the RegenSeq community across multiplexed imaging, spatial transcriptomics, and optical pooled screening.

Dr. Dan-Avi Landau, a world-renowned cancer researcher and pioneering geneticist, has been appointed inaugural chair of the newly created Department of Systems and Computational Biomedicine. The new ...

The next generation of cancer research models has arrived. An international consortium led by CSHL and @NorthwellHealth has developed more than 150 organoid models representing actual patient tumors s...

Read about New Study Reveals Distinct Biological Drivers of Cognitive Impairment in ALS at the New York Genome Center on August 4, 2026

🧠New NIH-funded research has uncovered an aspect of human brain aging that reshapes our approach to age-related cognitive decline and dementia risk. This knowledge will be critical as we work toward ...

Read about Gene Regulation Map Reveals Treatment Targets for Heart Failure at the New York Genome Center on July 27, 2026

Read about New Study Revises Understanding of Brain Immune Cells During Human Aging at the New York Genome Center on July 23, 2026

Read about Cancer Evolution Study Reveals Biology of Glioma Progression at the New York Genome Center on July 10, 2026

Read about New York Genome Center aims to lower barriers to spatial multi-omics with NIH funding at the New York Genome Center on July 1, 2026

Short tandem repeats (STRs) are a common type of genetic variation within the human genome and are defined as DNA segments composed of tandemly repeated nucleotide motifs that are usually 2-6 base pai...

Read about New York Genome Center Core Faculty Member, Dr. Dan Landau, Receives Award for Research on New Ovarian Cancer Targets at the New York Genome Center on June 16, 2026

YouTube video by Satija Lab

Read about Turning GWAS signals into drug targets with scalable CRISPR at the New York Genome Center on May 26, 2026

Read about NYGC Researchers Develop Lancet2, a Faster and More Accurate Tool for Detecting Complex Genetic Variants at the New York Genome Center on April 7, 2026

Find a career with New York Genome Center

Read about Tuuli Lappalainen, PhD Receives Prestigious European Society of Human Genetics Award at the New York Genome Center on March 25, 2026

TDP-43 is an RNA and DNA binding protein that plays major roles in regulating RNA processing. In particular, TDP-43 dysfunction leads to the accumulation of cryptic splice isoforms that result from im...

cSplotch compares spatial transcriptomics data across ages and regions of mouse colon tissue.

NY-CURES is working to advance bold, state-backed investment in biomedical research—on the scale of successful initiatives in California and Texas—to grow New York’s leadership in science, innovation, and health.